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Antibiotic stewardship (AS) teams are essential actors for combatting antibiotic-50	
resistant bacteria in healthcare and community settings, and are routinely mentioned in 51	
national and international guidelines, recommendations and action plans. Usually, AS teams 52	
in resource-rich settings are multidisciplinary, made up of different experts, commonly 53	
including infectious diseases (ID) specialists, clinical microbiologists and pharmacists, 54	
adequately trained in antibiotic prescribing and stewardship [1]. Some studies conducted in 55	
low- and middle-income countries (LMICs) have also shown that community health workers, 56	
nurses, village women, and others have important roles [1]. Antibiotic stewardship teams are 57	
in charge of implementing AS programmes in a specific setting (hospital, community, long-58	
term care facility) or sometimes in different settings, using a cross-sectoral approach [1]. 59	
 60	
Despite the importance of stewardship teams in optimising the management of 61	
infections, they remain understaffed or non-existent in most countries [2], and when they do 62	
exist, they tend to be focused in hospitals, even though the vast majority of antibiotics are 63	
prescribed in the community. A few countries have implemented regulatory measures making 64	
hospital stewardship teams mandatory (e.g. Australia, Belgium, Canada, France, Germany, 65	
the Netherlands, Norway, UK or the US), but even these requirements are not always 66	
enforced in practice. 67	
 68	
Two main actions are required to meet the human resource needs for stewardship 69	
across countries; first, there is a need for staffing standards (e.g. n full-time equivalent [FTE] 70	
per capita), based on the list of core actions stewardship teams must implement. Second, a 71	
sustainable funding mechanism is needed to ensure that experts in stewardship are employed 72	
and have dedicated time for their task. Accepted international norms and standards for 73	
infection prevention and control practitioners (per number of hospital beds) have been 74	
developed and implemented in some high-income countries, although high heterogeneity still 75	
exists at global level. A recently published literature review concluded that ‘an effective 76	
infection-control programme in an acute-care hospital must include as a minimum standard at 77	
least one full-time specifically trained infection-control nurse per up to 250 beds and a 78	
dedicated physician trained in infection control’ [3]. 79	
 80	
To the best of our knowledge, only a handful of countries have established staffing 81	
standards for stewardship teams, and these figures only exist for hospitals [4]. The 2016 82	
European Centre for Disease prevention and Control (ECDC) ‘Proposals for European Union 83	
(EU) guidelines on the prudent use of antimicrobials in humans’ recommended salary support 84	
and dedicated time for antimicrobial stewardship hospital-based activities, for example 2-6 85	
FTE per 1000 acute care beds, based on an expert consensus and citing French and German-86	
Austrian recommendations [5-7]. American colleagues recently suggested 2 FTE ID 87	
physician and 1 FTE ID-trained clinical pharmacist for every 1000 acute care hospital beds in 88	
the US [8]. In 2017, members of ESGAP (the ESCMID Study Group for Antimicrobial 89	
stewardshiP) from 26 different countries replied to a short e-mail survey about staffing 90	
recommendations in their own country; these only existed at national level for hospital-based 91	
stewardship teams in Australia, Canada, France, Germany, and the Netherlands (Table). The 92	
observed variation in staffing figures comes from the use of different methodologies to 93	
calculate the standards, and also reflects different healthcare systems and organisation of care.  94	
Importantly, the list of core activities of AS teams also varies between countries. In 95	
some countries, such as the Netherlands, some baseline functions of ID physicians, 96	
microbiologists and pharmacists may not be accounted for in the FTE staffing figures, as they 97	
are already considered standard of care. Also in Belgium, as of July 2007, all acute care 98	
hospitals and chronic care hospitals with >150 beds receive financial support from the federal 99	
government for hiring a trained antibiotic treatment manager for their AS teams. To this end, 100	
an annual budget of 4.3 million euros is divided among hospitals according to their number of 101	
beds (around 81,700 euros per 1000 beds, corresponding to 0.8 FTE/1000 beds) [9]. The 102	
funding however only concerns one person supervising implementation of the AS 103	
programme, not the whole AS team needed to implement all actions on a daily basis (e.g. 104	
ward rounds, systematic advice for specific situations…). On the contrary, in France, the list 105	
of core activities AS teams have to implement is much longer, and includes supervision of the 106	
programme as well as actions such as daily advice to prescribers; hospital-based AS teams are 107	
also expected to participate in AS activities in outpatient regional networks [7]. A list of core 108	
AS activities certainly needs to be agreed upon globally, in addition to the list of basic 109	
resources (e.g. diagnostics, pharmacy services) that must be in place for an AS programme to 110	
function properly. 111	
 112	
The need for a global funding mechanism to address human resources for stewardship, 113	
infection prevention and other non-drug development measures has been highlighted [10], but 114	
remains elusive. Although more keenly felt in LMICs, we believe that it is pertinent to all 115	
countries, as sustainable protected time for stewardship activities is often lacking. The role of 116	
the funding would be to train and retain core healthcare professionals and provide essential 117	
support staff (e.g. administrative staff and data support). Funding for AS should not come 118	
from the assumed cost savings deriving from the lower drugs expenses, but rather should be 119	
an inherent part of patient safety and healthcare quality-related spending. 120	
This is especially urgent given the increasing difficulty to bring new antibiotics to 121	
market and the dramatic sums of public money that will likely be needed to do so. While the 122	
cost of stewardship will seem very small relative to these R&D investments it must not be an 123	
afterthought [11]. Indeed it is essential that future stewardship activity has its own earmarked 124	
funding stream within any new antibiotic incentive scheme if we are to have any chance of 125	
protecting these new drugs if and when they make to market.  126	
 127	
In conclusion, it is time we focussed more on optimising the use of antibiotics, 128	
globally. We need further studies to identify the minimum international staffing standards for 129	
stewardship teams. This should go beyond hospitals, and should include also the community 130	
setting and long-term care facilities. This call recognizes the fact that as standards are put in 131	
place, they must take into account different models of stewardship delivery, where both 132	
traditional role players and others such as non-specialist pharmacists, nurses, and community 133	
health workers can be part of AS teams. We call for the development of global estimates of 134	
funding needs for basic and core antibiotic stewardship activities across all healthcare settings 135	
(Box). This is the first step in a long road towards a global funding mechanism to ensure 136	
compliance with the standards.  137	
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TABLE – Staffing recommendations available at country level for antimicrobial 186	
stewardship teams in hospitals 187	
Country How these standards 
were defined 
 
Staffing standards Reference 
Australia 
 
Antimicrobial 
stewardship in 
Australian hospitals 
(Second edition due 
2017) 
There is no consensus on staffing 
recommendations in Australia within 
the national accreditation standards.  
 
Recommendations from 2011: 
clinicians in hospitals with existing 
programs suggest that for every 100 
acute beds, at least 10 hours (0.3 full-
time equivalent) of senior pharmacist 
and 3.5 hours (0.1 full-time 
equivalent) of lead clinician time per 
week should be dedicated to AMS 
activities. Minimum for the team: 4 
FTE/1000 acute care beds. 
For rural regional hospitals access to 
experts through networks or 
telehealth is recommended. 
 
[12] 
Canada Based on an 
environmental scan, 
survey of the medical 
literature, and expert 
opinion of the 
Antimicrobial 
Stewardship and 
Resistance Committee 
Core Team Members (minimum 
recommended): total of 4.9 
FTE/1000 acute care beds 
Physician: 1.0 FTE per 1000 acute 
care beds 
Pharmacist: 3.0 FTE per 1000 acute 
care beds 
Project/Program Administrative and 
Coordination Support: 0.5 FTE per 
1000 acute care beds 
Data Analyst: 0.4 FTE per 1000 
acute care beds 
 
[13]  
Austria 
and 
Germany 
Guideline by the 
German Society for 
Infectious Diseases, 
based on the literature 
and expert advice 
Antibiotic stewardship team: 
minimum of 2 FTE per 1000 beds. 
The team should consist of at least 
one infectious diseases physician (or 
clinician with infectious diseases 
training) and an experienced clinical 
pharmacist/hospital pharmacist, as 
well as a specialist in microbiology. 
 
[6]  
France 
 
Nationwide survey in 
65 hospitals, 
conducted in 2015 by 
Optimal standards for the whole 
AMS team: 
- 3.6 FTE/1000 acute care beds for 
 [7] 
a Task force on 
antimicrobial 
resistance coordinated 
by the Ministry of 
Health 
infection specialists (medical 
doctors, ideally infectious diseases 
specialists) 
- 2.5 FTE/1000 acute care beds for 
pharmacists 
- and 0.6 FTE/1000 acute care beds 
for microbiologists 
- i.e. a total of 6.7 FTE/1000 acute 
care beds for the whole AMS team 
 
The 
Netherlan
ds 
 
National consensus 
procedure  
 
Optimal standards for the whole 
AMS team: 
 
Start-up phase 
Hospital < 300 beds 
-100 hours one time + 0.87 FTE per 
year 
Hospital 300 – 750 beds 
-100 hours one time + 1.2 FTE per 
year 
Hospital > 750 beds  
-100 hours one time + 2.5 FTE per 
year 
 
Consolidation phase 
Hospital < 300 beds : 1.25 FTE per 
year 
Hospital 300 – 750 beds : 2.14 FTE 
per year 
Hospital > 750 beds : 3.0 FTE / year 
 
[14] 
AMS : Antimicrobial stewardship; FTE : full-time equivalent  188	
BOX – Steps urgently needed to move forward 189	
1. Draw up minimum staffing standards for antibiotic stewardship teams that can be 
used globally. The simplest place to start is probably hospital-based stewardship activities. 
The first step would be to come up with a list of core antibiotic stewardship activities that 
would be applicable worldwide, based on a literature review and consensus procedure 
involving an international panel of experts. The next step would be to estimate the human 
resources needed to complete all these activities, based on data coming from existing fully 
implemented and successful programmes in a representative sample of hospitals, completed 
by experts’ opinion. 
2. Apply costs to these standards for a sample of low-, middle- and high-income 
countries. 
3. Identify potential funding sources to support health systems to cover these costs. 
 190	
